More articles from Basic

You have access
Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Olivier Barret, Lei Zhang, David Alagille, Cristian C. Constantinescu, Christine Sandiego, Caroline Papin, Jenna M. Sullivan, Thomas Morley, Vincent M. Carroll, John Seibyl, Jianqing Chen, Chewah Lee, Anabella Villalobos, David Gray, Timothy J. McCarthy and Gilles Tamagnan

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1307-1313; DOI: https://doi.org/10.2967/jnumed.120.256008
You have access
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Samaneh Azargoshasb, Krijn H.M. Houwing, Paul R. Roos, Sven I. van Leeuwen, Michael Boonekamp, Elio Mazzone, Kevin Bauwens, Paolo Dell’Oglio, Fijs W.B. van Leeuwen and Matthias N. van Oosterom

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1314-1317; DOI: https://doi.org/10.2967/jnumed.120.259796
You have access
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression
Stephanie Robu, Antonia Richter, Dario Gosmann, Christof Seidl, David Leung, Wendy Hayes, Daniel Cohen, Paul Morin, David J. Donnelly, Daša Lipovšek, Samuel J. Bonacorsi, Adam Smith, Katja Steiger, Christina Aulehner, Angela M. Krackhardt and Wolfgang A. Weber

Journal of Nuclear Medicine September 1, 2021, 62 (9) 1228-1234; DOI: https://doi.org/10.2967/jnumed.120.258384
You have access
Imaging Calreticulin for Early Detection of Immunogenic Cell Death During Anticancer Treatment
Dong-Yeon Kim, Ayoung Pyo, Misun Yun, Ramar Thangam, Sung-Hwan You, Ying Zhang, Ye-rim Jung, Dinh-Huy Nguyen, Akhil Venu, Hyeon Sik Kim, Mee Sun Yoon, Yeongjin Hong and Jung-Joon Min

Journal of Nuclear Medicine July 1, 2021, 62 (7) 956-960; DOI: https://doi.org/10.2967/jnumed.120.245290
You have access
Mechanisms of Resistance to Prostate-Specific Membrane Antigen–Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer
Andreea D. Stuparu, Joseph R. Capri, Catherine A.L. Meyer, Thuc M. Le, Susan L. Evans-Axelsson, Kyle Current, Mark Lennox, Christine E. Mona, Wolfgang P. Fendler, Jeremie Calais, Matthias Eiber, Magnus Dahlbom, Johannes Czernin, Caius G. Radu, Katharina Lückerath and Roger Slavik

Journal of Nuclear Medicine July 1, 2021, 62 (7) 989-995; DOI: https://doi.org/10.2967/jnumed.120.256263
You have access
Preclinical Evaluation of ²¹³Bi- and ²²⁵Ac-Labeled Low-Molecular-Weight Compounds for Radiopharmaceutical Therapy of Prostate Cancer
Sangeeta Ray Banerjee, Ala Lisok, Il Minn, Anders Josefsson, Vivek Kumar, Mary Brummet, Srikanth Boinapally, Cory Brayton, Ronnie C. Mease, George Sgouros, Robert F. Hobbs and Martin G. Pomper

Journal of Nuclear Medicine July 1, 2021, 62 (7) 980-988; DOI: https://doi.org/10.2967/jnumed.120.256388
You have access
Cyclotron-Produced ¹³²La as a PET Imaging Surrogate for Therapeutic ²²⁵Ac
Eduardo Aluicio-Sarduy, Todd E. Barnhart, Jamey Weichert, Reinier Hernandez and Jonathan W. Engle

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1012-1015; DOI: https://doi.org/10.2967/jnumed.120.255794
Open Access
Quantification of Macrophage-Driven Inflammation During Myocardial Infarction with ¹⁸F-LW223, a Novel TSPO Radiotracer with Binding Independent of the rs6971 Human Polymorphism
Mark G. MacAskill, Agne Stadulyte, Lewis Williams, Timaeus E.F. Morgan, Nikki L. Sloan, Carlos J. Alcaide-Corral, Tashfeen Walton, Catriona Wimberley, Chris-Anne McKenzie, Nick Spath, William Mungall, Ralph BouHaidar, Marc R. Dweck, Gillian A. Gray, David E. Newby, Christophe Lucatelli, Andrew Sutherland, Sally L. Pimlott and Adriana A.S. Tavares

Journal of Nuclear Medicine April 1, 2021, 62 (4) 536-544; DOI: https://doi.org/10.2967/jnumed.120.243600
You have access
Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating ESR1 Mutation
Manoj Kumar, Kelley Salem, Justin J. Jeffery, Yongjun Yan, Aparna M. Mahajan and Amy M. Fowler

Journal of Nuclear Medicine April 1, 2021, 62 (4) 500-506; DOI: https://doi.org/10.2967/jnumed.120.249508
You have access
¹⁷⁷Lu-Labeled Albumin-Binder–Conjugated PSMA-Targeting Agents with Extremely High Tumor Uptake and Enhanced Tumor-to-Kidney Absorbed Dose Ratio
Hsiou-Ting Kuo, Kuo-Shyan Lin, Zhengxing Zhang, Carlos F. Uribe, Helen Merkens, Chengcheng Zhang and François Bénard

Journal of Nuclear Medicine April 1, 2021, 62 (4) 521-527; DOI: https://doi.org/10.2967/jnumed.120.250738

Main menu

User menu

Search

More articles from Basic

Pages